{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:55:51Z","timestamp":1770746151810,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":2503,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1093\/annonc\/mds464","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T03:55:37Z","timestamp":1351569337000},"page":"674-679","source":"Crossref","is-referenced-by-count":36,"title":["Incidence and predictors of ovarian function recovery (OFR) in breast cancer (BC) patients with chemotherapy-induced amenorrhea (CIA) who switched from tamoxifen to exemestane"],"prefix":"10.1016","volume":"24","author":[{"given":"A.","family":"Guerrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gavil\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Folkerd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Climent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Guillem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mds464_bb0010","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1200\/JCO.2009.26.3756","article-title":"American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer","volume":"28","author":"Burstein","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds464_bb0015","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2013\u2013dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mds464_bb0020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study","volume":"20","author":"Geisler","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds464_bb0025","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1200\/JCO.2009.23.9616","article-title":"Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women","volume":"28","author":"Dunbier","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds464_bb0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/GCO.0b013e32833beebf","article-title":"Letrozole for ovulation induction and controlled ovarian hyperstimulation","volume":"22","author":"Pritts","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1093\/annonc\/mds464_bb0035","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1200\/JCO.2010.29.7689","article-title":"Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial","volume":"29","author":"Ganz","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds464_bb0040","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2005.05.3694","article-title":"Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds464_bb0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3816\/CBC.2006.n.026","article-title":"Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons","volume":"7","author":"Burstein","year":"2006","journal-title":"Clin Breast Cancer"},{"key":"10.1093\/annonc\/mds464_bb0050","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1210\/jc.2003-030824","article-title":"Menopause transition: Annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause","volume":"89","author":"Landgren","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mds464_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr960","article-title":"Deficits in plasma oestradiol measurement in studies and management of breast cancer","volume":"7","author":"Dowsett","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1093\/annonc\/mds464_bb0060","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/jc.2005-2378","article-title":"Comparison of methods to measure low serum estradiol levels in postmenopausal women","volume":"91","author":"Lee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mds464_bb0065","first-page":"1957","article-title":"Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route","volume":"47","author":"Dowsett","year":"1987","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mds464_bb0070","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2005.03.3969","article-title":"Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study","volume":"24","author":"Petrek","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds464_bb0075","first-page":"4043","article-title":"Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients","volume":"40","author":"Rose","year":"1980","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mds464_bb0080","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1200\/JCO.2008.18.6213","article-title":"Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE Trial","volume":"27","author":"Rossi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds464_bb0085","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/humrep\/deh508","article-title":"Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation","volume":"19","author":"La Marca","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mds464_bb0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.GME.0000123642.76105.6E","article-title":"Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition","volume":"11","author":"van Rooij","year":"2004","journal-title":"Menopause"},{"key":"10.1093\/annonc\/mds464_bb0095","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/dep210","article-title":"Anti-Mullerian hormone (AMH): what do we still need to know?","volume":"24","author":"La Marca","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mds464_bb0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/gme.0b013e318204af88","article-title":"Undetectable antim\u00fcllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor","volume":"18","author":"Dieudonn\u00e9","year":"2011","journal-title":"Menopause"},{"key":"10.1093\/annonc\/mds464_bb0105","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.25037","article-title":"Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy","volume":"116","author":"Yu","year":"2010","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds464_bb0110","first-page":"2089","article-title":"In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients","volume":"4","author":"Geisler","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"suppl","key":"10.1093\/annonc\/mds464_bb0115","first-page":"24S","article-title":"Outcomes of Women Who Were Premenopausal at Diagnosis of Early Stage Breast Cancer in the NCIC CTG MA17 Trial","volume":"69","author":"Goss","year":"2009","journal-title":"Cancer Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419371236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419371236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/3\/674\/13788667\/mds464.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T21:42:55Z","timestamp":1714513375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419371236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0923753419371236"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds464","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}